Jorge Simental, APRN
Acute Care · Hutchinson, KSNPI 1578155099
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (49.4%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Inspire Medical Systems, Inc. accounts for 66.4% of it on its own, with 28 other manufacturers making up the rest. 2025 is the largest year on record at $2,971, more than ten times the $243 reported in 2021. Among acute care clinicians in KS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 130 payments — averaging $45.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$4K
- AstraZeneca$301
- Jazz Pharmaceuticals Inc.$276
- Sanofi$167
- Harmony Biosciences LLC$143
- Titan Surgical Group, LLC$100
- plus $987 from 23 others
What the payments were for
- Consulting fees$1503%
- Travel & lodging$2,72046%
- Food & beverage$2,90149%
- Education$1012%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 40 | $3,898 |
| AstraZeneca | 10 | $301 |
| Jazz Pharmaceuticals Inc. | 4 | $276 |
| Sanofi | 13 | $167 |
| Harmony Biosciences LLC | 8 | $143 |
| Titan Surgical Group, LLC | 1 | $100 |
| Pulmonx Corporation | 1 | $79 |
| GSK | 4 | $78 |
| United Therapeutics Corporation | 3 | $73 |
| AbbVie | 5 | $72 |
| Regeneron Healthcare Solutions, Inc. | 4 | $70 |
| Novo Nordisk | 5 | $65 |
| Amgen | 3 | $63 |
| Pfizer | 4 | $62 |
| Actelion Pharmaceuticals US, Inc. | 3 | $56 |
| Axsome Therapeutics, Inc. | 2 | $52 |
| Verona Pharma, Inc. | 3 | $51 |
| Resmed Corp | 2 | $47 |
| Merck | 3 | $40 |
| Grifols USA, LLC | 2 | $30 |
| Sanofi Pasteur Inc. | 2 | $25 |
| Electromed, Inc. | 1 | $21 |
| Viatris Specialty LLC | 1 | $17 |
| Exact Sciences | 1 | $17 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
| Lilly USA, LLC | 1 | $13 |
| Genentech USA, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,872 in reported general payments places this provider in the 90th percentile of 113 acute care providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LumryzSodium Oxybate | 15 | $255,269 |
| WakixPitolisant Hcl | 12 | $195,524 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 189 | $138,672 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 87 | $58,995 |
| Breo ElliptaFluticasone/Vilanterol | 22 | $8,136 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 13 | $5,607 |
| Modafinil | 12 | $4,409 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 130 | $3,178 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 23 | $2,258 |
| Ventolin HfaAlbuterol Sulfate | 16 | $994 |
| Montelukast Sodium | 84 | $647 |
| Ropinirole Hcl | 22 | $99 |
| Pantoprazole Sodium | 12 | $92 |
| Prednisone | 48 | $85 |
| Gabapentin | 18 | $75 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Avadel CNS Pharmaceuticals, LLCLumryz | $16 | $255,26915 claims |
| Harmony Biosciences LLCWakix | $143 | $195,52412 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $78 | $152,415224 claims |
| AstraZenecaBreztri Aerosphere | $301 | $58,99587 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 113 acute care providers in Kansas.
Other acute care in Hutchinson
- Nicole BadeHutchinson$3K
- Elisa BrownHutchinson$857
- Mandy WoodHutchinson$347
- Susan MooreOttawa$31K
- Jennifer WatkinsKansas City$23K
- Stephanie LiningerShawnee Mission$15K
- Nicole WaltonOverland Park$14K
- Sarah KrejciLeawood$12K
- Lesa FullerWichita$9K
- Kristi DuchanoisKansas City$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.